Q32 Bio Inc.
NASDAQ:QTTBBiotechnology
Healthcare
$8.48 -1.70%
-$0.22 today
- Market cap
- $253.75M
- Beta
- -0.23
- P/E (TTM)
- 5.4
- EPS (TTM)
- $2.36
52W Low $1.35High $14.85
Volume 0.31M
Average 0.74M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$33.54M
FY 2025 · Annual
Investing Cash Flow
$7.00M
FY 2025 · Annual
-64.9% YoYFinancing Cash Flow
-$3.13M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (95.76M) | (42.81M) | (53.74M) | (47.73M) | 29.82M |
| Depreciation & Amortization | 9.54M | 370K | 499K | 487K | 391K |
| Deferred Income Tax | 0 | 2.43M | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 1.24M | 1.43M | 4.39M | 5.26M |
| Change in Working Capital | (41.8M) | 26.94M | 26.32M | (9.64M) | (4.04M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (2.49M) | (1.24M) | 2.03M | (1.04M) | (2.11M) |
| Other Working Capital | (39.32M) | 28.18M | 24.28M | (8.59M) | (1.93M) |
| Other Non-Cash Items | 18.27M | 876K | 6.82M | (15.22M) | (64.97M) |
| Operating Cash Flow | (109.75M) | (10.96M) | (18.68M) | (67.72M) | (33.54M) |
| Capital Expenditures | (2.4M) | (2.49M) | (5K) | (75K) | 0 |
| Acquisitions (Net) | 0 | 130M | 0 | 0 | 0 |
| Purchases of Investments | (97.39M) | (157.46M) | 0 | 0 | 0 |
| Sales of Investments | 49M | 65.46M | 0 | 20M | 0 |
| Other Investing Activities | 0 | (37.98M) | 0 | 0 | 7M |
| Investing Cash Flow | (50.79M) | (2.47M) | (5K) | 19.93M | 7M |
| Debt Repayment | 0 | 30M | 300K | 7M | (3.13M) |
| Common Stock Issued | 52.17M | 69K | 106K | 42M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 46.14M | 0 |
| Financing Cash Flow | 52.17M | 30.07M | 406K | 95.14M | (3.13M) |
| Effect of Forex Changes | (679K) | 0 | 9.91M | 0 | 0 |
| Net Change in Cash | (109.05M) | 16.65M | (8.37M) | 47.35M | (29.67M) |
| Free Cash Flow | (112.15M) | (13.44M) | (18.68M) | (67.79M) | (33.54M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$29.8M
+ D&A$391.0K
+ Stock-Based Comp$5.3M
+ Deferred Tax$0
- Working Capital-$4.0M
- Other Non-Cash-$65.0M
= Operating Cash Flow-$33.5M
- Capex$0
= Free Cash Flow-$33.5M
Analysis
FY2025 free cash flow is -$33.5M. FCF conversion is -112.5% of net income. Operating cash flow was -$33.5M, with capex of $0. The largest bridge item is Other Non-Cash at -$65.0M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| SC 13G | SC 13G filing | Oct 28, 2026 |
Does QTTB generate free cash flow?
Q32 Bio Inc. (QTTB) generated -$33.54M of free cash flow in fiscal 2025.
How much operating cash flow does QTTB produce?
Operating cash flow was -$33.54M, before capital expenditures of $0.00.
Continue the stock analysis
Jump to another research area for this company.